Leadership & Pay ·
Century Therapeutics, Inc. entered into an Amended and Restated Employment Agreement with Chief Scientific Officer…
IPSCCentury Therapeutics, Inc.
Century Therapeutics, Inc. entered into an Amended and Restated Employment Agreement with Chief Scientific Officer Chad Cowan, Ph.D., effective June 15, 2026. Under the terms of part-time status, Dr. Cowan will receive a reduced annual salary of $296,150 and remains eligible for a pro-rated performance-based target bonus. Century Therapeutics, Inc. is a biotechnology company focused on developing cell therapies for cancer and autoimmune diseases.